- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide, Dexamethasone
Total 4307 results
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina
-
Brown UniversityMemorial Hospital of Rhode Island; Roger Williams Medical CenterCompleted
-
CelgeneCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
Poitiers University HospitalCompletedMultiple Myeloma | Impaired Renal FunctionFrance
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnLymphoma | Follicular Lymphoma
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPeripheral T-cell Lymphomas (PTCL)Taiwan
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
King Faisal Specialist Hospital & Research CenterCompleted
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Peking Union Medical College HospitalRecruiting
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixTexas Tech UniversityNot yet recruitingCognitive Dysfunction | Neurodegenerative Disease, Hereditary | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, Brain
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory Peripheral T-cell LymphomaChina
-
CelgeneActive, not recruitingMultiple MyelomaNetherlands, Belgium, Denmark, Germany, United Kingdom, France, Norway, Spain, Austria, Ireland, Italy, Sweden
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
CelgeneTerminatedMultiple MyelomaChina
-
Nordic MDS GroupCompleted
-
University Health Network, TorontoCelgene CorporationCompleted
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Beijing Friendship HospitalRecruiting
-
German CLL Study GroupCelgeneCompletedChronic Lymphocytic LeukemiaGermany
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
TelikCompletedMyelodysplastic SyndromeUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedFollicular LymphomaFrance
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
Samyang Biopharmaceuticals CorporationChungnam National University HospitalCompleted
-
Bristol-Myers SquibbAbbVieCompleted